Natco Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 05/11/2018, to consider and approve approval of the Unaudited Financial Results for the quarter ended 30th September, 2018, and considreation of buy-back of equity shares of the Company and related matters.
The above information is a part of company’s filings submitted to BSE.